This inventor holds 3 USPTO granted patents. Top assignees: Astellas Pharma Gmbh, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shizuoka, JP (2006 - 2011)
- Fujietda, JP (2011)
Company Filing History:

Years Active: 2006-2011
Title: Shigeo Takemura: Innovator in Pharmaceutical Composition
Introduction
Shigeo Takemura is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of drug absorption. With a total of 3 patents to his name, Takemura's work focuses on improving the efficacy of biologically active peptides.
Latest Patents
Takemura's latest patents include a pharmaceutical composition for oral use with improved absorption. This invention relates to an agent that inhibits the decomposition of biologically active peptides by digestive enzymes. The effective ingredient in this composition is aminoalkyl methacrylate copolymer E. The invention also details methods for reducing the viscosity of the gastrointestinal mucosa and enhancing the permeability of biologically active peptides. These advancements allow for excellent oral absorption of peptides that were previously difficult to absorb.
Career Highlights
Throughout his career, Takemura has worked with prominent companies in the pharmaceutical industry, including Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd. His expertise in drug formulation and absorption has positioned him as a key figure in pharmaceutical innovation.
Collaborations
Takemura has collaborated with notable colleagues such as Shunsuke Watanabe and Yuuki Tsutsui. These partnerships have contributed to the development of his innovative pharmaceutical compositions.
Conclusion
Shigeo Takemura's contributions to the field of pharmaceuticals, particularly in improving drug absorption, highlight his role as an influential inventor. His work continues to impact the effectiveness of oral medications, paving the way for advancements in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile